Index Catalog // Hyrax

Filter löschen

Filtern nach: Contributor Pan, Dong Study Program Molecular Medicine Study Program (MolMed)

Beschreibung:: Background BRAF mutations are common in melanoma, with more than 50% harboring activating BRAF mutations. Though BRAF inhibitors are highly efficacious for nearly half of patients with this BRAF-mutant melanoma, many developing secondary resistance...
Datum erstellt:: August 1-2, 2024

Suche beschränken